PLCE1 and focal segmental glomerulosclerosis: A less severe course characterized by FSGS and slower progression to end stage renal failure has been reported in patients with PLCE1 missense mutations, implying a genotype–phenotype correlation and suggesting the clinical relevance of genetic testing [35].